XBiotech Inc. financial data

Symbol
XBIT on Nasdaq
Location
5217 Winnebago Lane, Austin, TX
State of incorporation
British Columbia, Canada
Fiscal year end
December 31
Latest financial report
10-K - Q4 2024 - Mar 18, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 1.16K % -72.9%
Debt-to-equity 9.23 % +222%
Return On Equity -19.8 % -82.5%
Return On Assets -18.1 % -71.8%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 30.5M shares +0.12%
Common Stock, Shares, Outstanding 30.5M shares +0.17%
Entity Public Float 122M USD -13.2%
Common Stock, Value, Issued 273M USD +0.72%
Weighted Average Number of Shares Outstanding, Basic 30.5M shares +0.07%

Income Statement

Label TTM Value / Value Unit Change %
Research and Development Expense 37.8M USD +14.9%
General and Administrative Expense 4.71M USD +1.12%
Operating Income (Loss) -42.5M USD -13.2%
Nonoperating Income (Expense) 3.91M USD -70.4%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -38.6M USD -58.6%
Income Tax Expense (Benefit) -32K USD -113%
Net Income (Loss) Attributable to Parent -38.5M USD -56.9%
Earnings Per Share, Basic -1.26 USD/shares -55.6%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 173M USD -13.7%
Accounts Receivable, after Allowance for Credit Loss, Current 730K USD -17.1%
Assets, Current 175M USD -13.5%
Property, Plant and Equipment, Net 24.5M USD -1.49%
Assets 199M USD -12.1%
Accounts Payable, Current 2.22M USD -11.6%
Employee-related Liabilities, Current 611K USD +8.72%
Accrued Liabilities, Current 2.63M USD -24.8%
Liabilities, Current 15.1M USD +148%
Accrued Income Taxes, Noncurrent 1.72M USD +3.06%
Deferred Income Tax Liabilities, Net 0 USD -100%
Liabilities 16.8M USD +117%
Accumulated Other Comprehensive Income (Loss), Net of Tax 0 USD -100%
Retained Earnings (Accumulated Deficit) -90.8M USD -73.7%
Stockholders' Equity Attributable to Parent 182M USD -16.7%
Liabilities and Equity 199M USD -12.1%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -7.2M USD -49.8%
Net Cash Provided by (Used in) Financing Activities 10.1M USD
Net Cash Provided by (Used in) Investing Activities -255K USD -4150%
Common Stock, Shares, Issued 30.5M shares +0.17%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 1.02M USD
Deferred Tax Assets, Valuation Allowance 26.4M USD +50.1%
Deferred Tax Assets, Gross 26.8M USD +47.1%
Depreciation 432K USD -2.48%
Payments to Acquire Property, Plant, and Equipment 255K USD +4150%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -38.5M USD -51.8%
Deferred Tax Assets, Operating Loss Carryforwards 2.8M USD +117%
Unrecognized Tax Benefits 3.43M USD +15.5%
Preferred Stock, Shares Outstanding 0 shares
Deferred Tax Assets, Net of Valuation Allowance 395K USD -37.1%
Share-based Payment Arrangement, Expense 1.75M USD -46.3%